通过依赖于LKB1的方式调节ILC2铁,α-Tocopherol可以改善过敏呼吸道炎症
Xiaogang Zhang1, Jingping Liu2, Ziyang Chen3
1Pediatric Intensive Care Unit, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences); Department of Immunology, School of Basic Medical Sciences; Department of Clinical Laboratory, the Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou 510515, China; Department of Immunology, School of Basic Medical Sciences; Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Southern Medical University, Guangzhou 510515, China.
维生素E成分α-托科菲罗尔 (α-Toc) 通过抑制2组先天性淋巴细胞 (ILC2) 中的B类清除受体1 (SCARB1) 和LKB1-AMPK/mTOR通路来调节过敏呼吸道炎症. 这表明α-Toc是一种潜在的喘治疗方法.
科学领域:
- 免疫学
- 细胞生物学
- 营养科学
背景情况:
- 饮食免疫可以调节过敏的呼吸道炎症.
- 2组先天性淋巴细胞 (ILC2) 是过敏气道炎症的关键媒介.
研究的目的:
- 确定调节ILC2介导的过敏呼吸道炎症的饮食成分.
- 阐明alpha-tocopherol (α-Toc) 对ILC2s和过敏呼吸道炎症的影响的分子机制.
主要方法:
- 接受α-Toc治疗的小鼠肺部ILC2s的转录组分析.
- 使用基因缺陷或关键路径的药理抑制的小鼠进行体内研究 (LKB1,SCARB1).
- 人类ILC2s的ex vivo培养以评估α-Toc的作用.
主要成果:
- α-Toc治疗降低了SCARB1的表达,并抑制了肺部ILC2中的LKB1-AMPK/ mTOR通路.
- 缺乏LKB1或SCARB1对抗性导致ILC2的丰度,功能和肺炎的降低.
- 在LKB1缺乏的小鼠中,α-Toc未能改善炎症,这表明LKB1的关键作用.
- 通过调节KLF4-GPX4复合体,LKB1缺乏促进了ILC2s中的铁亡,减少了肺炎.
- 在人体ILC2中,α-Toc抑制了ILC2激活和LKB1介导的铁.
结论:
- 通过向LKB1-AMPK/mTOR通路并促进ILC2铁亡,α-Toc作为过敏气道炎症的饮食调节剂.
- ILC2s中的LKB1介导铁是过敏呼吸道炎症的关键机制.
- 由于它能够抑制ILC2激活和铁死,α-Toc显示出治疗喘的潜力.
相关概念视频
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...


